Exploring feature-based approaches in PET images for predicting cancer treatment outcomes
- PMID: 20161266
- PMCID: PMC2701316
- DOI: 10.1016/j.patcog.2008.08.011
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes
Abstract
Accumulating evidence suggests that characteristics of pre-treatment FDG-PET could be used as prognostic factors to predict outcomes in different cancer sites. Current risk analyses are limited to visual assessment or direct uptake value measurements. We are investigating intensity-volume histogram metrics and shape and texture features extracted from PET images to predict patient's response to treatment. These approaches were demonstrated using datasets from cervix and head and neck cancers, where AUC of 0.76 and 1.0 were achieved, respectively. The preliminary results suggest that the proposed approaches could potentially provide better tools and discriminant power for utilizing functional imaging in clinical prognosis.
Figures








Similar articles
-
Predicting pathologic tumor response to chemoradiotherapy with histogram distances characterizing longitudinal changes in 18F-FDG uptake patterns.Med Phys. 2013 Oct;40(10):101707. doi: 10.1118/1.4820445. Med Phys. 2013. PMID: 24089897 Free PMC article.
-
CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.Radiother Oncol. 2021 Feb;155:174-181. doi: 10.1016/j.radonc.2020.10.006. Epub 2020 Oct 16. Radiother Oncol. 2021. PMID: 33069764 Free PMC article.
-
CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas.Eur Radiol. 2017 Mar;27(3):1012-1020. doi: 10.1007/s00330-016-4470-8. Epub 2016 Jul 5. Eur Radiol. 2017. PMID: 27380902 Free PMC article.
-
Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment.Mol Imaging Biol. 2011 Oct;13(5):801-11. doi: 10.1007/s11307-010-0426-6. Mol Imaging Biol. 2011. PMID: 21136185 Review.
-
The role of baseline 18F-FDG PET/CT for survival prognosis in NSCLC patients undergoing immunotherapy: a systematic review and meta-analysis.Ther Adv Med Oncol. 2024 Nov 4;16:17588359241293364. doi: 10.1177/17588359241293364. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39502406 Free PMC article. Review.
Cited by
-
State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.J Gastrointest Oncol. 2015 Feb;6(1):3-19. doi: 10.3978/j.issn.2078-6891.2014.062. J Gastrointest Oncol. 2015. PMID: 25642333 Free PMC article. Review.
-
Reply to: Area under the cumulative SUV-volume histogram is not a viable metric of intratumoral metabolic heterogeneity.Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1469-70. doi: 10.1007/s00259-013-2474-z. Epub 2013 Jun 11. Eur J Nucl Med Mol Imaging. 2013. PMID: 23754764 No abstract available.
-
Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model.Mol Imaging Biol. 2015 Oct;17(5):697-703. doi: 10.1007/s11307-015-0840-x. Mol Imaging Biol. 2015. PMID: 25761907
-
Pretreatment (18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma--a retrospective study.Radiat Oncol. 2015 Jan 8;10:4. doi: 10.1186/s13014-014-0268-5. Radiat Oncol. 2015. PMID: 25566697 Free PMC article.
-
A Machine Learning-Based Predictive Model of Epidermal Growth Factor Mutations in Lung Adenocarcinomas.Cancers (Basel). 2022 Sep 25;14(19):4664. doi: 10.3390/cancers14194664. Cancers (Basel). 2022. PMID: 36230590 Free PMC article.
References
-
- Biersack HJ, Bender H, Palmedo H. FDG-PET in monitoring therapy of breast cancer. Eur J Nucl Med Mol Imaging. 2004;31 1:S112–7. - PubMed
-
- Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;59:78–86. - PubMed
-
- Mutic S, Malyapa RS, Grigsby PW, et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys. 2003;55:28–35. - PubMed
-
- Brun E, Kjellen E, Tennvall J, et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck. 2002;24:127–35. - PubMed
-
- Hope AJ, Saha P, Grigsby PW. FDG-PET in carcinoma of the uterine cervix with endometrial extension. Cancer. 2006;106:196–200. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources